<?xml version="1.0" encoding="UTF-8"?>
<p id="par0030">The rapid and devastating outbreak of Coronavirus disease 2019 (COVID-19) pandemic and the lack of approved treatments for any human coronavirus (CoV) infection highlight the urgent need to develop strategies to prevent infection, control virus spreading and disease exacerbation. Several options can be envisaged, ranging from prophylactic vaccine to targeted antiviral drugs. However, new interventions are likely to require months to years to be readily-available, thus priority is being given to the repurposing of existing antiviral agents [
 <xref rid="bib0005" ref-type="bibr">1</xref>].
</p>
